Skip to content
YCS20· AI

Nabla Bio

We use AI to design antibodies for intractable diseases

ActiveChecked 18h ago
Batch
S20
Status, per YC
Active
Team size
8
HQ
Boston, MA
In S20209 companies, 28% AI
nabla.bioYC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About Nabla Bio

Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.

Boston, MA, USA

Nabla Bio: questions

Which YC batch was Nabla Bio in?

Nabla Bio was in Y Combinator's Summer 2020 batch (S20).

Is Nabla Bio still active?

Y Combinator lists Nabla Bio as active.

Where is Nabla Bio based?

Nabla Bio lists Boston, MA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.